Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07342582 · ClinicalTrials.gov registry record

The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study

A clinical trial, sponsored by University of Wisconsin, Madison.

Not yet
Registry status
670
Enrollment target

NCT07342582 is a clinical trial that has not yet begun recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 670 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07342582 has not yet begun recruiting, sponsored by University of Wisconsin, Madison.

NOT YET RECRUITING
Registry status
670 participants
Enrollment target

Study Summary

The goal of this study is to determine the burden of Rhinoviruses (RVs) as a cause of acute, severe, respiratory illnesses leading to hospitalization. A community cohort of 120 children between 12 and 36 months of age will be enrolled in the first year of the study and followed (when well and sick) for 36 months to identify the circulating RVs and provide samples to establish a host nasal transcriptome differentiating clinical from subclinical RV infections. A hospitalized cohort of 450 infants and children will be enrolled during years 1 through 3 of the study and followed for the duration of their hospitalization to investigate the findings of the community cohort. An additional 100 healthy children aged 5-17 years will be enrolled for age-match comparison with the older hospitalized cohort.

Interventions

  • DIAGNOSTIC_TEST Nasal Swab Healthy Surveillance
  • DIAGNOSTIC_TEST Nasal Swab Sick Samples
  • DIAGNOSTIC_TEST Nasal Swab Hospitalized Cohort
  • OTHER Sick Follow-up Survey
  • OTHER Older Cohort Control Group

Trial Details

FieldValue
Enrollment Target 670 participants
Start Date 2026-05
Est. Completion 2030-05

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT07342582

The ClinicalTrials.gov registry entry for NCT07342582 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 670 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Nasal Swab Healthy Surveillance is the first listed.

NCT07342582 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07342582 about?

NCT07342582 is a clinical study titled "The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study". The goal of this study is to determine the burden of Rhinoviruses (RVs) as a cause of acute, severe, respiratory illnesses leading to hospitalization. A community cohort of 120 children between 12 and 36 months of age will be enrolled in the first year of the study and followed (when well and sick) ...

What is the current status of trial NCT07342582?

This trial is currently not yet recruiting. The enrollment target is 670 participants. The study started on 2026-05. Estimated completion is 2030-05.

What interventions are being tested in trial NCT07342582?

The interventions under investigation include: Nasal Swab Healthy Surveillance (DIAGNOSTIC_TEST), Nasal Swab Sick Samples (DIAGNOSTIC_TEST), Nasal Swab Hospitalized Cohort (DIAGNOSTIC_TEST), Sick Follow-up Survey (OTHER), Older Cohort Control Group (OTHER).

Who is sponsoring clinical trial NCT07342582?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.